Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Edwards Lifesciences restructuring: Cardiovascular technology firm announces planned mid-year departures of corporate VPs Anita B. Bessler, Stuart L. Foster and Alex Martin, along with "strengthened alignment" into a business-unit organizational structure. Corporate VPs Donald E. Bobo, Paul C. Redmond, Carlyn D. Solomon and Larry L. Wood will take on additional U.S. sales, marketing and operational duties in their units, reporting to CEO Michael A. Mussallem. Bessler and Foster will continue in advisory roles with the company

You may also be interested in...



ev3, FoxHollow Merger Creates Peripheral Vascular Leviathan

Endovascular device makers ev3 and FoxHollow are combining their respective strong European and U.S. sales forces in a merger announced July 22

Big Win For EMA On Transparency

The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.

UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector
UsernamePublicRestriction

Register

MT025816

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel